Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 104 Pages
Report ld: 4153031
Request Sample
Customized Report
The global market for Hydroxyurea API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
It has the appearance of white crystal or crystal powder, which can resist tumor and inhibit mitosis of cells. CAS number is 127-07-1.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hydroxyurea API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hydroxyurea API by region & country, by Type, and by Application.
The Hydroxyurea API market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxyurea API.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hydroxyurea API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hydroxyurea API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hydroxyurea API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hydroxyurea API Product Introduction
1.2 Global Hydroxyurea API Market Size Forecast
1.2.1 Global Hydroxyurea API Sales Value (2020-2031)
1.2.2 Global Hydroxyurea API Sales Volume (2020-2031)
1.2.3 Global Hydroxyurea API Sales Price (2020-2031)
1.3 Hydroxyurea API Market Trends & Drivers
1.3.1 Hydroxyurea API Industry Trends
1.3.2 Hydroxyurea API Market Drivers & Opportunity
1.3.3 Hydroxyurea API Market Challenges
1.3.4 Hydroxyurea API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hydroxyurea API Players Revenue Ranking (2024)
2.2 Global Hydroxyurea API Revenue by Company (2020-2025)
2.3 Global Hydroxyurea API Players Sales Volume Ranking (2024)
2.4 Global Hydroxyurea API Sales Volume by Company Players (2020-2025)
2.5 Global Hydroxyurea API Average Price by Company (2020-2025)
2.6 Key Manufacturers Hydroxyurea API Manufacturing Base and Headquarters
2.7 Key Manufacturers Hydroxyurea API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hydroxyurea API
2.9 Hydroxyurea API Market Competitive Analysis
2.9.1 Hydroxyurea API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Hydroxyurea API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydroxyurea API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity ≥ 98 %
3.1.2 Purity ≥ 99 %
3.2 Global Hydroxyurea API Sales Value by Type
3.2.1 Global Hydroxyurea API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Hydroxyurea API Sales Value, by Type (2020-2031)
3.2.3 Global Hydroxyurea API Sales Value, by Type (%) (2020-2031)
3.3 Global Hydroxyurea API Sales Volume by Type
3.3.1 Global Hydroxyurea API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Hydroxyurea API Sales Volume, by Type (2020-2031)
3.3.3 Global Hydroxyurea API Sales Volume, by Type (%) (2020-2031)
3.4 Global Hydroxyurea API Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hydroxyurea Oral
4.1.2 Hydroxyurea Injection
4.2 Global Hydroxyurea API Sales Value by Application
4.2.1 Global Hydroxyurea API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Hydroxyurea API Sales Value, by Application (2020-2031)
4.2.3 Global Hydroxyurea API Sales Value, by Application (%) (2020-2031)
4.3 Global Hydroxyurea API Sales Volume by Application
4.3.1 Global Hydroxyurea API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Hydroxyurea API Sales Volume, by Application (2020-2031)
4.3.3 Global Hydroxyurea API Sales Volume, by Application (%) (2020-2031)
4.4 Global Hydroxyurea API Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Hydroxyurea API Sales Value by Region
5.1.1 Global Hydroxyurea API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Hydroxyurea API Sales Value by Region (2020-2025)
5.1.3 Global Hydroxyurea API Sales Value by Region (2026-2031)
5.1.4 Global Hydroxyurea API Sales Value by Region (%), (2020-2031)
5.2 Global Hydroxyurea API Sales Volume by Region
5.2.1 Global Hydroxyurea API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Hydroxyurea API Sales Volume by Region (2020-2025)
5.2.3 Global Hydroxyurea API Sales Volume by Region (2026-2031)
5.2.4 Global Hydroxyurea API Sales Volume by Region (%), (2020-2031)
5.3 Global Hydroxyurea API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Hydroxyurea API Sales Value, 2020-2031
5.4.2 North America Hydroxyurea API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Hydroxyurea API Sales Value, 2020-2031
5.5.2 Europe Hydroxyurea API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Hydroxyurea API Sales Value, 2020-2031
5.6.2 Asia Pacific Hydroxyurea API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Hydroxyurea API Sales Value, 2020-2031
5.7.2 South America Hydroxyurea API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hydroxyurea API Sales Value, 2020-2031
5.8.2 Middle East & Africa Hydroxyurea API Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hydroxyurea API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Hydroxyurea API Sales Value
6.2.1 Key Countries/Regions Hydroxyurea API Sales Value, 2020-2031
6.2.2 Key Countries/Regions Hydroxyurea API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Hydroxyurea API Sales Value, 2020-2031
6.3.2 United States Hydroxyurea API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Hydroxyurea API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Hydroxyurea API Sales Value, 2020-2031
6.4.2 Europe Hydroxyurea API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Hydroxyurea API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Hydroxyurea API Sales Value, 2020-2031
6.5.2 China Hydroxyurea API Sales Value by Type (%), 2024 VS 2031
6.5.3 China Hydroxyurea API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Hydroxyurea API Sales Value, 2020-2031
6.6.2 Japan Hydroxyurea API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Hydroxyurea API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Hydroxyurea API Sales Value, 2020-2031
6.7.2 South Korea Hydroxyurea API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Hydroxyurea API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Hydroxyurea API Sales Value, 2020-2031
6.8.2 Southeast Asia Hydroxyurea API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Hydroxyurea API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Hydroxyurea API Sales Value, 2020-2031
6.9.2 India Hydroxyurea API Sales Value by Type (%), 2024 VS 2031
6.9.3 India Hydroxyurea API Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 DSM Pharma Chemicals
7.1.1 DSM Pharma Chemicals Company Information
7.1.2 DSM Pharma Chemicals Introduction and Business Overview
7.1.3 DSM Pharma Chemicals Hydroxyurea API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 DSM Pharma Chemicals Hydroxyurea API Product Offerings
7.1.5 DSM Pharma Chemicals Recent Development
7.2 Nischem International
7.2.1 Nischem International Company Information
7.2.2 Nischem International Introduction and Business Overview
7.2.3 Nischem International Hydroxyurea API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Nischem International Hydroxyurea API Product Offerings
7.2.5 Nischem International Recent Development
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Information
7.3.2 Bristol-Myers Squibb Introduction and Business Overview
7.3.3 Bristol-Myers Squibb Hydroxyurea API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bristol-Myers Squibb Hydroxyurea API Product Offerings
7.3.5 Bristol-Myers Squibb Recent Development
7.4 Amri
7.4.1 Amri Company Information
7.4.2 Amri Introduction and Business Overview
7.4.3 Amri Hydroxyurea API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Amri Hydroxyurea API Product Offerings
7.4.5 Amri Recent Development
7.5 Olon SPA
7.5.1 Olon SPA Company Information
7.5.2 Olon SPA Introduction and Business Overview
7.5.3 Olon SPA Hydroxyurea API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Olon SPA Hydroxyurea API Product Offerings
7.5.5 Olon SPA Recent Development
7.6 Qilu Pharmaceutial
7.6.1 Qilu Pharmaceutial Company Information
7.6.2 Qilu Pharmaceutial Introduction and Business Overview
7.6.3 Qilu Pharmaceutial Hydroxyurea API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Qilu Pharmaceutial Hydroxyurea API Product Offerings
7.6.5 Qilu Pharmaceutial Recent Development
7.7 Khandelwal Laboratories
7.7.1 Khandelwal Laboratories Company Information
7.7.2 Khandelwal Laboratories Introduction and Business Overview
7.7.3 Khandelwal Laboratories Hydroxyurea API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Khandelwal Laboratories Hydroxyurea API Product Offerings
7.7.5 Khandelwal Laboratories Recent Development
7.8 Yaksh Pharma
7.8.1 Yaksh Pharma Company Information
7.8.2 Yaksh Pharma Introduction and Business Overview
7.8.3 Yaksh Pharma Hydroxyurea API Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Yaksh Pharma Hydroxyurea API Product Offerings
7.8.5 Yaksh Pharma Recent Development
8 Industry Chain Analysis
8.1 Hydroxyurea API Industrial Chain
8.2 Hydroxyurea API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hydroxyurea API Sales Model
8.5.2 Sales Channel
8.5.3 Hydroxyurea API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Hydroxyurea API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 127
USD 3950.00
(Single User License)
The global Hydroxyurea API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 129
USD 2900.00
(Single User License)
The global Hydroxyurea API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 135
USD 4900.00
(Single User License)
The global Hydroxyurea API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 76
USD 4250.00
(Single User License)
The global market for Hydroxyurea API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 91
USD 2900.00
(Single User License)
It has the appearance of white crystal or crystal powder, which can resist tumor and inhibit mitosis of cells. CAS number is 127-07-1.
Published Date: 2024-04-16
Pages: 96
USD 4900.00
(Single User License)
It has the appearance of white crystal or crystal powder, which can resist tumor and inhibit mitosis of cells. CAS number is 127-07-1.
Published Date: 2024-01-25
Pages: 100
USD 3950.00
(Single User License)
It has the appearance of white crystal or crystal powder, which can resist tumor and inhibit mitosis of cells. CAS number is 127-07-1.
Published Date: 2024-01-11
Pages: 87
USD 2900.00
(Single User License)
The global market for Hydroxyurea API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 127
The global Hydroxyurea API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 129
The global Hydroxyurea API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 135
The global Hydroxyurea API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 76
The global market for Hydroxyurea API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 91
It has the appearance of white crystal or crystal powder, which can resist tumor and inhibit mitosis of cells. CAS number is 127-07-1.
Published: 2024-04-16
Pages: 96
It has the appearance of white crystal or crystal powder, which can resist tumor and inhibit mitosis of cells. CAS number is 127-07-1.
Published: 2024-01-25
Pages: 100
It has the appearance of white crystal or crystal powder, which can resist tumor and inhibit mitosis of cells. CAS number is 127-07-1.
Published: 2024-01-11
Pages: 87
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now